Back
Kratos Defense & Security Solutions 10K Form
Buy
52
KTOS
Kratos Defense & Security Solutions
Last Price:
23.95
Seasonality Move:
-1.49%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive KTOS News And Ratings
See the #1 stock for the next 7 days that we like better than KTOS
KTOS Financial Statistics
Sales & Book Value
| Annual Sales: | $1.04B |
|---|---|
| Cash Flow: | $-15.4M |
| Price / Cash Flow: | 1244.9 |
| Annual Sales: | $8.82 |
| Price / Book: | 2.63 |
Profitability
| EPS (TTM): | 0.07000 |
|---|---|
| Net Income (TTM): | $10M |
| Gross Margin: | $268.6M |
| Return on Equity: | 0.9% |
| Return on Assets: | 0.58% |
Kratos Defense & Security Solutions Earnings Forecast
Key Kratos Defense & Security Solutions Financial Ratios
- The Gross Profit Margin over the past 26 years for KTOS is 25.90%.
- The Selling, General & Administrative Expenses for KTOS have been equal to 19.07% of Gross Profit Margin.
- The Research & Development expenses have been 3.70% of Revenue.
- The Interest Expense is -243.82% of Operating Income.
- The Net Earning history of KTOS is -0.86% of Total Revenues.
- Per Share Earnings over the last 26 years have been positive in 14 years.
Kratos Defense & Security Solutions Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Aerospace & Defense |
| Sector: | Industrials |
| Current Symbol: | KTOS |
| CUSIP: | 50077B |
| Website: | kratosdefense.com |
Debt
| Debt-to-Equity Ratio: | 0.14 |
|---|---|
| Current Ratio: | 3.13 |
| Quick Ratio: | 2.37 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 39.87 |
KTOS Technical Analysis vs Fundamental Analysis
Buy
52
Kratos Defense & Security Solutions (KTOS)
is a Buy
Is Kratos Defense & Security Solutions a Buy or a Sell?
-
Kratos Defense & Security Solutions stock is rated a Buy
The current Kratos Defense & Security Solutions [KTOS] share price is $24.29. The Score for KTOS is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.